Community Use of Antibiotics in Turkey: The Role of Knowledge, Beliefs, Attitudes, and Health Anxiety.
antibiotics
antimicrobial resistance
attitudes
beliefs
community
health anxiety
knowledge
self-medication
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
27 Sep 2021
27 Sep 2021
Historique:
received:
23
08
2021
revised:
18
09
2021
accepted:
24
09
2021
entrez:
23
10
2021
pubmed:
24
10
2021
medline:
24
10
2021
Statut:
epublish
Résumé
Turkey has been among the leading countries in antibiotic consumption. As a result of the 4-year National Action Plan for Rational Drug Use, antibiotic prescriptions had declined from 34.9% in 2011 to 24.6% in 2018. However, self-medication with antibiotics without prescription is common, which is not reflected in official statistics. The present study aims at investigating antibiotic use in the community and the factors related to it. A web-based survey was conducted among 945 Turkish-speaking respondents (61.3% female). The questionnaire included questions about antibiotic use for different illnesses, ways to obtain and handle leftover antibiotics, knowledge, beliefs of the antibiotic effectiveness, attitudes, health anxiety, and background factors. According to the results, 34.2% of the sample had self-medicated themselves with antibiotics without a valid prescription. The most common way to self-medicate was to use leftover antibiotics. While 80.4% knew that antibiotics are used to treat bacterial infections, 51.4% thought that antibiotics are effective for viral diseases. The most important predictor of antibiotic use frequency was the belief in their efficiency for various illnesses and symptoms, followed by negative attitudes to antibiotics, health anxiety, knowledge level, positive attitudes, and health status. The results underline the importance of targeting misbeliefs about antibiotics in future campaigns.
Identifiants
pubmed: 34680752
pii: antibiotics10101171
doi: 10.3390/antibiotics10101171
pmc: PMC8532753
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Antimicrob Resist Infect Control. 2021 Feb 4;10(1):29
pubmed: 33541440
Arch Med Sci. 2013 Oct 31;9(5):854-7
pubmed: 24273569
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3463-E3470
pubmed: 29581252
J Antimicrob Chemother. 2008 May;61(5):1172-9
pubmed: 18296694
Scand J Infect Dis. 2002;34(5):366-71
pubmed: 12069022
BMC Health Serv Res. 2008 Jun 06;8:123
pubmed: 18538009
Antibiotics (Basel). 2019 Oct 07;8(4):
pubmed: 31591303
Interdiscip Perspect Infect Dis. 2018 Aug 8;2018:8492740
pubmed: 30174690
Int J Clin Pract. 2021 Jan;75(1):e13665
pubmed: 32772449
J Antimicrob Chemother. 2018 Jul 1;73(7):1984-1988
pubmed: 29590400
BMC Infect Dis. 2016 Jan 08;16:7
pubmed: 26746228
Br J Psychol. 2021 Aug;112(3):804-827
pubmed: 33543779
Health Commun. 2021 Jan 27;:1-10
pubmed: 33499691
Clin Microbiol Infect. 2019 Jun;25(6):651-653
pubmed: 30844434
Int J Clin Pharm. 2015 Dec;37(6):1213-21
pubmed: 26391787
BMC Public Health. 2019 Nov 26;19(1):1558
pubmed: 31771595
Lancet Infect Dis. 2014 May;14(5):381-7
pubmed: 24657114
Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1242-1249
pubmed: 34155708
Clin Microbiol Infect. 2014 Oct;20(10):973-80
pubmed: 25273968
PLoS One. 2011 Mar 28;6(3):e18241
pubmed: 21464898
J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi37-45
pubmed: 22096065
BMC Public Health. 2021 Jun 2;21(1):1041
pubmed: 34078338
BMC Public Health. 2015 Aug 01;15:742
pubmed: 26231758
Psychol Med. 2002 Jul;32(5):843-53
pubmed: 12171378
BMC Public Health. 2021 Jun 3;21(1):1056
pubmed: 34082726